Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidia...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bec2e1891000414c81f06c4114983ed8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bec2e1891000414c81f06c4114983ed8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bec2e1891000414c81f06c4114983ed82021-11-25T17:45:52ZDefining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol10.3390/healthcare91115392227-9032https://doaj.org/article/bec2e1891000414c81f06c4114983ed82021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9032/9/11/1539https://doaj.org/toc/2227-9032In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidiabetics treatments; this increases the risk of potentially inappropriate prescriptions (PIPs) of hypoglycaemic agents (HAs). Inappropriate prescribing can be assessed by approaches that are implicit (expert judgement based) or explicit (criterion based). In a mixed, multistep process, we first systematically reviewed the published definitions of PIPs for HAs in patients with T2DM. The results will be used to create the first list of explicit definitions. Next, we will complete the definitions identified in the systematic review by conducting a qualitative study with two focus groups of experts in the prescription of HAs. Lastly, a Delphi survey will then be used to build consensus among participants; the results will be validated in consensus meetings. We developed a method for determining explicit definitions of PIPs for HAs in patients with T2DM. The resulting explicit definitions could be easily integrated into computerised decision support tools for the automated detection of PIPs.Paul QuindroitNicolas BacletErwin GerardLaurine RobertMadleen LemaitreSophie GautierChloé Delannoy-RousselièreBertrand DécaudinAnne VambergueJean-Baptiste BeuscartMDPI AGarticlestudy protocoltype 2 diabeteshypoglycaemic agentspotentially inappropriate prescriptionsinappropriate prescribingmethodology researchMedicineRENHealthcare, Vol 9, Iss 1539, p 1539 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
study protocol type 2 diabetes hypoglycaemic agents potentially inappropriate prescriptions inappropriate prescribing methodology research Medicine R |
spellingShingle |
study protocol type 2 diabetes hypoglycaemic agents potentially inappropriate prescriptions inappropriate prescribing methodology research Medicine R Paul Quindroit Nicolas Baclet Erwin Gerard Laurine Robert Madleen Lemaitre Sophie Gautier Chloé Delannoy-Rousselière Bertrand Décaudin Anne Vambergue Jean-Baptiste Beuscart Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
description |
In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidiabetics treatments; this increases the risk of potentially inappropriate prescriptions (PIPs) of hypoglycaemic agents (HAs). Inappropriate prescribing can be assessed by approaches that are implicit (expert judgement based) or explicit (criterion based). In a mixed, multistep process, we first systematically reviewed the published definitions of PIPs for HAs in patients with T2DM. The results will be used to create the first list of explicit definitions. Next, we will complete the definitions identified in the systematic review by conducting a qualitative study with two focus groups of experts in the prescription of HAs. Lastly, a Delphi survey will then be used to build consensus among participants; the results will be validated in consensus meetings. We developed a method for determining explicit definitions of PIPs for HAs in patients with T2DM. The resulting explicit definitions could be easily integrated into computerised decision support tools for the automated detection of PIPs. |
format |
article |
author |
Paul Quindroit Nicolas Baclet Erwin Gerard Laurine Robert Madleen Lemaitre Sophie Gautier Chloé Delannoy-Rousselière Bertrand Décaudin Anne Vambergue Jean-Baptiste Beuscart |
author_facet |
Paul Quindroit Nicolas Baclet Erwin Gerard Laurine Robert Madleen Lemaitre Sophie Gautier Chloé Delannoy-Rousselière Bertrand Décaudin Anne Vambergue Jean-Baptiste Beuscart |
author_sort |
Paul Quindroit |
title |
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
title_short |
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
title_full |
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
title_fullStr |
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
title_full_unstemmed |
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol |
title_sort |
defining potentially inappropriate prescriptions for hypoglycaemic agents to improve computerised decision support: a study protocol |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/bec2e1891000414c81f06c4114983ed8 |
work_keys_str_mv |
AT paulquindroit definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT nicolasbaclet definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT erwingerard definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT laurinerobert definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT madleenlemaitre definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT sophiegautier definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT chloedelannoyrousseliere definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT bertranddecaudin definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT annevambergue definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol AT jeanbaptistebeuscart definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol |
_version_ |
1718412069223530496 |